-
Banaschewski, T, Soutullo, C, Lecendreux, M, Johnson, M, Zuddas, A, Hodgkins, P, Adeyi, B, Squires, LA, Coghill, DR.
EPA-1078 – The child health and illness profile as a measure of health-related quality of life in stimulant-treated children and adolescents with ADHD.
European Psychiatry
29:
1
2014
view publication
-
Coghill, DR, Banaschewski, T, Lecendreux, M, Soutullo, C, Johnson, M, Zuddas, A, Anderson, C, Civil, R, Dauphin, M, Lyne, A, et al.
EPA-1407 – The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
European Psychiatry
29:
1
2014
view publication
-
Holden, SE, Jenkins-Jones, S, Poole, CD, Morgan, CL, Coghill, D, Currie, CJ.
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).
Child and Adolescent Psychiatry and Mental Health
7(1)
:
34
2013
view publication
-
Dittmann, RW, Cardo, E, Nagy, P, Anderson, CS, Bloomfield, R, Caballero, B, Higgins, N, Hodgkins, P, Lyne, A, Civil, R, et al.
Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study.
CNS Drugs
27(12)
:
1081 -1092
2013
view publication
-
Coghill, D, Banaschewski, T, Zuddas, A, Pelaz, A, Gagliano, A, Doepfner, M.
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies.
BMC Psychiatry
13(1)
:
237
2013
view publication